Novo Nordisk’s Ozempic Gets FDA Approval
US FDA Approves Novo Nordisk's Ozempic to Cut Risk of Diabetic Kidney Disease Progression
The U.S. FDA has approved Novo Nordisk's Ozempic for reducing the risk of kidney failure and disease progression, as well as death due to heart problems in diabetes patients with chronic kidney disease (CKD),
Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.
Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey.
Novo, which competes with U.S. drugmaker Eli Lilly, makes the main active ingredient in its popular obesity and diabetes ...
Ozempic and Wegovy are made by Novo Nordisk, which is based in Denmark and has U.S. headquarters Plainsboro, New Jersey. Maryland’s federal workers ‘living life of uncertainty’ after Trump ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback